A detailed history of American Century Companies Inc transactions in Neogenomics Inc stock. As of the latest transaction made, American Century Companies Inc holds 3,094,611 shares of NEO stock, worth $42.4 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
3,094,611
Previous 1,990,692 55.45%
Holding current value
$42.4 Million
Previous $32.2 Million 51.04%
% of portfolio
0.03%
Previous 0.02%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

BUY
$14.06 - $16.79 $15.5 Million - $18.5 Million
1,103,919 Added 55.45%
3,094,611 $48.6 Million
Q4 2023

Feb 13, 2024

BUY
$11.67 - $20.73 $23.2 Million - $41.3 Million
1,990,692 New
1,990,692 $32.2 Million
Q3 2023

Nov 13, 2023

SELL
$12.15 - $17.85 $488,563 - $717,766
-40,211 Reduced 59.93%
26,882 $330,000
Q2 2023

Aug 14, 2023

BUY
$14.1 - $19.83 $287,752 - $404,690
20,408 Added 43.71%
67,093 $1.08 Million
Q1 2023

May 11, 2023

BUY
$9.09 - $19.45 $137,068 - $293,286
15,079 Added 47.71%
46,685 $812,000
Q4 2022

Feb 13, 2023

BUY
$6.45 - $12.07 $203,858 - $381,484
31,606 New
31,606 $292,000
Q2 2022

Aug 12, 2022

SELL
$7.06 - $13.97 $2.62 Million - $5.18 Million
-370,783 Closed
0 $0
Q1 2022

May 11, 2022

SELL
$12.15 - $35.28 $2.49 Million - $7.22 Million
-204,557 Reduced 35.55%
370,783 $4.51 Million
Q4 2021

Feb 07, 2022

SELL
$30.49 - $48.49 $1.26 Million - $2 Million
-41,313 Reduced 6.7%
575,340 $19.6 Million
Q3 2021

Nov 10, 2021

BUY
$41.66 - $52.52 $2.7 Million - $3.41 Million
64,886 Added 11.76%
616,653 $29.7 Million
Q2 2021

Aug 05, 2021

SELL
$36.62 - $51.69 $82,504 - $116,457
-2,253 Reduced 0.41%
551,767 $24.9 Million
Q1 2021

May 14, 2021

SELL
$41.56 - $59.88 $5.61 Million - $8.08 Million
-134,906 Reduced 19.58%
554,020 $26.7 Million
Q4 2020

Feb 12, 2021

BUY
$36.08 - $56.47 $2.9 Million - $4.55 Million
80,487 Added 13.23%
688,926 $37.1 Million
Q3 2020

Nov 13, 2020

SELL
$33.26 - $40.48 $2.2 Million - $2.67 Million
-66,080 Reduced 9.8%
608,439 $22.4 Million
Q2 2020

Aug 13, 2020

BUY
$24.21 - $31.02 $4.02 Million - $5.15 Million
165,912 Added 32.62%
674,519 $20.9 Million
Q1 2020

May 14, 2020

BUY
$20.5 - $34.53 $527,178 - $887,973
25,716 Added 5.33%
508,607 $14 Million
Q4 2019

Feb 12, 2020

BUY
$18.96 - $29.84 $1.23 Million - $1.94 Million
65,059 Added 15.57%
482,891 $14.1 Million
Q3 2019

Nov 13, 2019

SELL
$19.12 - $26.24 $5.18 Million - $7.11 Million
-270,791 Reduced 39.32%
417,832 $7.99 Million
Q2 2019

Aug 14, 2019

BUY
$19.57 - $24.1 $978,049 - $1.2 Million
49,977 Added 7.83%
688,623 $15.1 Million
Q1 2019

May 14, 2019

SELL
$12.14 - $20.46 $596,426 - $1.01 Million
-49,129 Reduced 7.14%
638,646 $0
Q4 2018

Feb 13, 2019

BUY
$11.24 - $18.5 $4.27 Million - $7.03 Million
380,041 Added 123.5%
687,775 $8.67 Million
Q3 2018

Nov 02, 2018

BUY
$12.5 - $15.38 $3.85 Million - $4.73 Million
307,734 New
307,734 $4.72 Million

Others Institutions Holding NEO

About NEOGENOMICS INC


  • Ticker NEO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 125,796,000
  • Market Cap $1.72B
  • Description
  • NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...
More about NEO
Track This Portfolio

Track American Century Companies Inc Portfolio

Follow American Century Companies Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of American Century Companies Inc, based on Form 13F filings with the SEC.

News

Stay updated on American Century Companies Inc with notifications on news.